A Study to Evaluate Effective Medical Management of Pregnancies with Type 2 Diabetes

Official Title: Medical Optimization & Management of Pregnancies With Overt Type 2 Diabetes (MOMPOD)


This study is being conducted in order to compare the safety and effectiveness of insulin vs. insulin plus metformin for treatment of Type 2 diabetes mellitus in pregnancy

Eligibility criteria:

- Maternal age 18-45 years at enrollment
- Single fetus with no known fetal anomalies
- Preexisting Type 2 diabetes requiring medical treatment (oral agent or insulin)
- Overt diabetes diagnosed at < 22 weeks 6 days gestation
- Willingness to use insulin and study agent only; no other diabetes medical therapy permitted while on study
- Gestational age at randomization between 10 weeks 0 days and 22 weeks 6

Contact Information

Anna Bartholomew, RN